# OnCo record paper-mina-lebanon-drug-registration-collapse-plosone-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mina-lebanon-drug-registration-collapse-plosone-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mina-lebanon-drug-registration-collapse-plosone-2025" ;
  schema:name "The collapse of new medicine registration in Lebanon after the 2019 crisis"@en ;
  schema:description "Before Lebanon's crisis, 43.6% of new FDA-approved medicines were registered in Lebanon; for those approved from 2020 to 2024 the figure was 0%, which interviewees linked to an informal policy to hold back costly new medicines."@en ;
  schema:url <https://onco.cc/key-papers/paper-mina-lebanon-drug-registration-collapse-plosone-2025/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://doi.org/10.1371/journal.pone.0330585>, <https://pubmed.ncbi.nlm.nih.gov/41452850/> ;
  schema:sameAs <https://doi.org/10.1371/journal.pone.0330585> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Mina W, Nahas H, Lteif MR, et al." ;
  onco:related <https://onco.cc/technologies/global-oncology-access/> ;
  onco:institutions <https://onco.cc/institutions/lebanon-ministry-of-public-health/> .
